Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
Authors
Keywords
Epilepsy, Drug therapy, Computer software, Pharmacokinetics, Sodium channels, Heredity, Pharmacodynamics, Retrospective studies
Journal
PLoS One
Volume 10, Issue 10, Pages e0141266
Publisher
Public Library of Science (PLoS)
Online
2015-10-21
DOI
10.1371/journal.pone.0141266
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RORA gene rs12912233 and rs880626 polymorphisms and their interaction with SCN1A rs3812718 in the risk of epilepsy: A case–control study in Malaysia
- (2015) Batoul Sadat Haerian et al. GENOMICS
- Epilepsy: new advances
- (2015) Solomon L Moshé et al. LANCET
- Population Pharmacokinetics of Valproic Acid in Adult Chinese Epileptic Patients and its Application in an Individualized Dosage Regimen
- (2015) Wei-wei Lin et al. THERAPEUTIC DRUG MONITORING
- A Population Pharmacokinetic Model of Valproic Acid in Pediatric Patients with Epilepsy: A Non-Linear Pharmacokinetic Model Based on Protein-Binding Saturation
- (2014) Junjie Ding et al. CLINICAL PHARMACOKINETICS
- Dravet syndrome-From epileptic encephalopathy to channelopathy
- (2014) Andreas Brunklaus et al. EPILEPSIA
- Pregnane X receptor and hepatocyte nuclear factor 4α polymorphisms are cooperatively associated with carbamazepine autoinduction
- (2014) Junji Saruwatari et al. Pharmacogenetics and Genomics
- Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy
- (2014) Chun-Lai Ma et al. PHARMACOGENOMICS
- Impact of the Superoxide Dismutase 2 Val16Ala Polymorphism on the Relationship between Valproic Acid Exposure and Elevation of γ-Glutamyltransferase in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
- (2014) Naoki Ogusu et al. PLoS One
- Drug treatment of epilepsy in adults
- (2014) D. Schmidt et al. BMJ-British Medical Journal
- Adverse drug reactions induced by valproic acid
- (2013) Radu M. Nanau et al. CLINICAL BIOCHEMISTRY
- Prognostic factors for medically intractable epilepsy: A systematic review
- (2013) Merel Wassenaar et al. EPILEPSY RESEARCH
- Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy
- (2013) Wenting Yun et al. EPILEPSY RESEARCH
- Valproic acid pathway
- (2013) Yogita Ghodke-Puranik et al. Pharmacogenetics and Genomics
- Alternative Splicing Modulates Inactivation of Type 1 Voltage-gated Sodium Channels by Toggling an Amino Acid in the First S3-S4 Linker
- (2011) Emily V. Fletcher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009
- (2010) Anne T. Berg et al. EPILEPSIA
- Coffee Induces Expression of Glucuronosyltransferases by the Aryl Hydrocarbon Receptor and Nrf2 in Liver and Stomach
- (2010) Sandra Kalthoff et al. GASTROENTEROLOGY
- Association betweenSCN1Apolymorphism and carbamazepine-resistant epilepsy
- (2008) Tomohide Abe et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search